These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37789128)

  • 41. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
    Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
    J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interdisciplinary fracture liaison service improves health-related outcomes and survival of older adults after hip fracture surgical repair.
    Ruggiero C; Baroni M; Talesa GR; Cirimbilli A; Prenni V; Bubba V; Parretti L; Bogini R; Duranti G; Caraffa A; Boccardi V; Mecocci P; Rinonapoli G
    Arch Osteoporos; 2022 Oct; 17(1):135. PubMed ID: 36251126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study.
    Lih A; Nandapalan H; Kim M; Yap C; Lee P; Ganda K; Seibel MJ
    Osteoporos Int; 2011 Mar; 22(3):849-58. PubMed ID: 21107534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Ferrari S; Adachi JD; Lippuner K; Zapalowski C; Miller PD; Reginster JY; Törring O; Kendler DL; Daizadeh NS; Wang A; O'Malley CD; Wagman RB; Libanati C; Lewiecki EM
    Osteoporos Int; 2015 Dec; 26(12):2763-71. PubMed ID: 26068295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Greenspan SL; Singer A; Vujevich K; Marchand B; Thompson DA; Hsu YJ; Vaidya D; Stern LS; Zeldow D; Lee DB; Karp S; Recker R
    Osteoporos Int; 2018 Apr; 29(4):953-960. PubMed ID: 29429033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a 12-month analysis.
    Inderjeeth CA; Raymond WD; Briggs AM; Geelhoed E; Oldham D; Mountain D
    Osteoporos Int; 2018 Aug; 29(8):1759-1770. PubMed ID: 29704027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS).
    Ljunggren O; Benhamou CL; Dekker J; Kapetanos G; Kocjan T; Langdahl BL; Napoli N; Petto H; Nikolić T; Lindh E
    Curr Med Res Opin; 2014 Aug; 30(8):1607-16. PubMed ID: 24720366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association's Own the Bone Database.
    Robinson WA; Carlson BC; Poppendeck H; Wanderman NR; Bunta AD; Murphy S; Sietsema DL; Daffner SD; Edwards BJ; Watts NB; Tosi LL; Anderson PA; Freedman BA
    Spine (Phila Pa 1976); 2020 Apr; 45(8):E430-E438. PubMed ID: 31770343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice.
    Thomas T; Horlait S; Ringe JD; Abelson A; Gold DT; Atlan P; Lange JL
    Osteoporos Int; 2013 Jan; 24(1):263-9. PubMed ID: 22736069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
    Arch Osteoporos; 2021 Sep; 16(1):130. PubMed ID: 34510296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies.
    Silverman S; Langdahl BL; Fujiwara S; Saag K; Napoli N; Soen S; Enomoto H; Melby TE; Disch DP; Marin F; Krege JH
    Calcif Tissue Int; 2019 Feb; 104(2):193-200. PubMed ID: 30343436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fracture prevention service to bridge the osteoporosis care gap.
    Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML
    Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does a fracture liaison service program minimize recurrent fragility fractures in the elderly with osteoporotic vertebral compression fractures?
    Wasfie T; Jackson A; Brock C; Galovska S; McCullough JR; Burgess JA
    Am J Surg; 2019 Mar; 217(3):557-560. PubMed ID: 30274804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A survey of outcomes and management of patients post fragility fractures in China.
    Wang O; Hu Y; Gong S; Xue Q; Deng Z; Wang L; Liu H; Tang H; Guo X; Chen J; Jia X; Xu Y; Lan L; Lei C; Dong H; Yuan G; Fu Q; Wei Y; Xia W; Xu L
    Osteoporos Int; 2015 Nov; 26(11):2631-40. PubMed ID: 25966892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of fracture liaison services in osteoporosis.
    Paccou J; Philippoteaux C; Cortet B; Fardellone P
    Joint Bone Spine; 2023 Sep; 90(5):105574. PubMed ID: 37080285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital.
    Kang MY; Besley J; Sun T; Paul S
    N Z Med J; 2020 May; 133(1515):16-24. PubMed ID: 32438373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased Mortality and Subsequent Fracture Risk in Patients With a Major and Hip Fracture After the Introduction of a Fracture Liaison Service: A 3-Year Follow-Up Survey.
    Vranken L; de Bruin IJA; Driessen AHM; Geusens PPM; Eisman JA; Center JR; van der Velde RY; Janzing HMJ; Kaarsemaker S; van den Bergh JP; Wyers CE
    J Bone Miner Res; 2022 Oct; 37(10):2025-2032. PubMed ID: 36087016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement in the primary and secondary prevention of osteoporosis by a Fracture Liaison Service: feedback from a single French center care pathway.
    Vrignaud A; Pelletier S; Dernis E; Moui Y; Haettich B
    Arch Osteoporos; 2018 Oct; 13(1):110. PubMed ID: 30324242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effectiveness of osteoporosis treatment in older patients: A fracture liaison service-based prospective study.
    Mugnier B; Daumas A; Couderc AL; Mizzi B; González T; Amrani A; Lévêque P; Aymes B; Argenson JN; Villani P
    J Women Aging; 2019; 31(6):553-565. PubMed ID: 30295566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
    Bilezikian JP; Lin CJF; Brown JP; Wang AT; Yin X; Ebeling PR; Fahrleitner-Pammer A; Franek E; Gilchrist N; Miller PD; Simon JA; Valter I; Zerbini CAF; Libanati C; Chines A
    Osteoporos Int; 2019 Sep; 30(9):1855-1864. PubMed ID: 31201481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.